comparemela.com
Latest Breaking News On - Akeso phase - Page 1 : comparemela.com
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06.
Canada
Japan
China
United-states
Texas
Chinese
America
American
Bob-duggan
Allen-yang
Brad-canino
Bradley-canino
vimarsana © 2020. All Rights Reserved.